Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-03-19
1994-08-02
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 81, 514256, 5142342, 544127, 544333, 546 23, 546118, A61K 31435, C07D47104
Patent
active
053345983
ABSTRACT:
Phenoxyphenylacetic acids and derivatives of general structural formula I have endothelin ##STR1## antagonist activity and are therefore useful in treating cardiovascular disorders, such as hypertension, congestive heart failure, postischemic renal failure, vasospasm, cerebral and cardiac ischemia, myocardial infarction, inflammatory diseases, Raynaud's disease, and endotoxic shock, and asthma.
REFERENCES:
patent: 5082838 (1992-01-01), Naka et al.
patent: 5114918 (1992-05-01), Ishikawa et al.
patent: 5177095 (1993-01-01), Greenlee et al.
patent: 5183810 (1993-02-01), Greenlee et al.
patent: 5187195 (1993-02-01), Oohata et al.
Bagley Scott W.
Chakravarty Prasun K.
Chen Anna
Dhanoa Daljit S.
Fitch Kenneth J.
Camara Valerie J.
Daniel Mark R.
Dentz Bernard
DiPrima Joseph F.
Merck & Co. , Inc.
LandOfFree
Six-membered ring fused imidazoles substituted with phenoxypheny does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Six-membered ring fused imidazoles substituted with phenoxypheny, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Six-membered ring fused imidazoles substituted with phenoxypheny will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-64993